Bajaj Healthcare receives license from DRDO to manufacture 2-DG

Bajaj Healthcare receives license from DRDO to manufacture 2-DG

by admin- Thursday, July 8th, 2021 06:28:48 PM

Bajaj Healthcare Limited (BHL) has received a licence from DRDO to Manufacture and Market of “2-Deoxy-D-Glucose” (2-DG) as accredited remedy for the remedy of COVID-19 sufferers.

News Updates